[1]
Nogueira, G.N. 2025. Duloxetine: The Next Gold Standard for Treating Depression and Motor Symptoms in Parkinson’s Disease?. Actas Españolas de Psiquiatría. 53, 3 (May 2025), 638–639. DOI:https://doi.org/10.62641/aep.v53i3.1864.